Pharmacists are integral to oncology care, optimizing treatment plans, managing adverse effects, and supporting precision medicine through collaborative practice agreements.

Marcus Flores, PharmD, BCPS, BCOP, discusses the vital role of pharmacists in multidisciplinary cancer care, exploring ...

Up to 4 million people may lose coverage, increasing uninsured rates, especially in non-Medicaid expansion states and among ...

Soft tissue sarcomas (STS) are rare malignant tumors arising from connective tissues such as muscle, fat, and blood vessels, ...

Sophia Humphreys, PharmD, MHA, BCBBS, discusses common barriers to cancer therapy and how care teams can assist patients in ...

Testosterone therapy lacks evidence for preventing muscle loss, bone fractures, heart disease, or cognitive decline in women.

Panelists discuss how: LDL-C control remains a national crisis, with many patients not on therapy or failing to reach target ...

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

MOG-IgG positivity is rare in MS patients, complicating diagnosis and treatment, especially in Asian populations with lower ...

Panelists discuss how schizophrenia’s immense personal and financial burden calls for early, integrated, and sustained care ...

MBS significantly reduces liver-related complications and other health risks in patients with SLD, including cardiovascular, ...

Access to glucagon-like peptide-1 (GLP-1) receptor agonists for obesity treatment could be expanded through innovative ...